Report Details

Global Hepatitis C Virus Testing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

ID : 7745291
Date : May 2019
Pages : 221 Pages
Industry : Pharmaceutical and Healthcare


Hepatitis C is a liver disease which is transmitted by the contact with the blood of an infected person. Hepatitis C show significant genetic variation in population worldwide, due to high rate of viral RNA mutations. HCV has six variants HCV genotypes 1, 2, 3, 4, 5, and 6, and 15 subtypes are recorded which vary in the rate of prevalence around the globe. Different types of devices are used for the diagnosis of hepatitis C, including HCV viral load test, HCV antibody test, HCV genotype test and liver biopsy. Inexpensive, rapid, robust, and sensitive analytical devices are essential for effective, accurate diagnosis and monitoring of disease treatment.



Increase in hepatitis C virus testing Market is mainly attributed to high incidence of chronic infection with hepatitis C virus. Furthermore, unhygienic blood donation practices are the considerable cause of spread of hepatitis C virus. Hepatitis C screening test is compulsory before the organ donation, increase in organ donation globally expected to boost the testing market growth. The increase in healthcare expenditure, changing lifestyle and increase in government initiatives are some of the key factors driving the growth of global hepatitis C virus antiviral Testing Market. In addition, growing healthcare awareness about the hepatitis C virus is also fueling the growth of global hepatitis C virus testing market. However, stringent regulation for approval of hepatitis C testing is the major factor expected to hamper the hepatitis C virus testing market.



Globally, hepatitis C virus testing market is segmented based on technique, test type, end-user.



Based on technique, hepatitis C virus testing market is segmented as:

Polymerase Chain Reaction Tests
Immunoassays
Others


Based on test, hepatitis C virus testing market is segmented as:

Hepatitis C antibody
Hepatitis C RNA quantitative test
Hepatitis C RNA qualitative test
Hepatitis C RIBA
Hepatitis C genotype
Viral load


Based on the end-user, hepatitis C virus testing market is segmented as:

Hospitals
Diagnostic Centres
Blood Donation centers


When compared to hepatitis A and hepatitis B Prevalence of hepatitis C is low. According to Institute of Liver and Biliary Sciences India ILBS around 3% of population globally, infected with hepatitis C virus, therefore minimum R&D investments by market players to develop new and effective hepatitis C virus tests. Among the all tests, HCV antibody testing is expected to occupy more share because antibody testing is the primarily used test for HCV testing. In end user segment, diagnostic centers is expected to have major market share in HCV testing market. Application of new electrochemical immune sensor and genosensor technologies in HPV testing are expected to change conventional HPV testing practices.



Geographically, hepatitis C virus testing Market is divided into Asia-Pacific, Latin America, North America, Europe and The Middle East and Africa. Europe hepatitis C market is expected to grow at significant rates owing to incidence of hepatitis C virus diseases. According to WHO European region have 1.5% and Eastern Mediterranean has 2.3% prevalence of HCV diseases that shows significant variations in genes in population globally due to high rates of mutation of viral RNA. Asia Pacific is expected to be having lucrative market growth over the forecasting period owing to disease prevalence rates.



Some of the players in global hepatitis C virus testing Market include Abbott Laboratories U.S., Bio Rad Laboratories Inc. U.S., Qiagen Germany, Bayer AG Switzerland, OraSure Technologies U.S., Siemens Healthcare GmbH Germany, BioGenex U.S., H. Hoffman-La Roche Ltd Switzerland, Thermo Fisher Scientific Inc. U.S., and Ortho Clinical Diagnostic Inc. U.S., among others.



In March 2018, Siemens Healthineer’s Versant HCV Genotype 2.0 line probe LiPA assay gained market approval from U.S. FDA for HCV testing


In October 2015, Hologic received CE‐IVD certification for its Aptima® HCV hepatitis C virus Quant Dx assay on the fully automated Panther® system


In May 2011, Abbott’s RealTime PCR polymerase chain reaction test received testing market approval from the U.S. Food and Drug Administration for measuring the viral load of hepatitis C HCV


In 2010, OraQuick HCV Rapid Antibody Test was approved by the U.S. FDA that became an alternative to enzyme immunoassay testing for HCV


Report Outline:



The report provides granular level information about the market size, regional market share and forecast from 2019-2025
The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
The report tracks recent innovations, key developments and startup’s details that are working in the industry
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. Executive summary
2. Global Hepatitis C Virus Testing Market Introduction
2.1. Global Hepatitis C Virus Testing Market– Taxonomy
2.2. Global Hepatitis C Virus Testing Market–Definitions
2.2.1. Test Type
2.2.2. Technique
3. Global Hepatitis C Virus Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Hepatitis C Virus Testing Market Dynamics – Factors Impact Analysis
3.6. Global Hepatitis C Virus Testing Market– Recent Market Introductions
4. Global Hepatitis C Virus Testing Market Analysis, 2014 - 2018 and Forecast, 2019 – 2025
4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
4.2. Year-over-Year Y-o-Y Growth Analysis %
4.3. Market Oppurtunity Analysis
5. Global Hepatitis C Virus Testing Market Forecast, By Test Type, 2014 - 2018 and Forecast, 2019 - 2025
5.1. Hepatitis C Antibody Test
5.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
5.1.3. Market Opportunity Analysis
5.2. Hepatitis C RNA Quantitative Test
5.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
5.2.3. Market Opportunity Analysis
5.3. Hepatitis C RNA Qualitative Test
5.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
5.3.3. Market Opportunity Analysis
5.4. Hepatitis C RIBA
5.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.4.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
5.4.3. Market Opportunity Analysis
5.5. Hepatitis C Genotype
5.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.5.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
5.5.3. Market Opportunity Analysis
5.6. Viral Load
5.6.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
5.6.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
5.6.3. Market Opportunity Analysis
6. Global Hepatitis C Virus Testing Market Forecast, By Technique, 2014 - 2018 and Forecast, 2019 - 2025
6.1. Polymerase Chain Reaction Tests
6.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
6.1.3. Market Opportunity Analysis
6.2. Immunoassays
6.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
6.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
6.3.3. Market Opportunity Analysis
7. Global Hepatitis C Virus Testing Market Forecast, By End User, 2014 - 2018 and Forecast, 2019 - 2025
7.1. Hospitals
7.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
7.1.3. Market Opportunity Analysis
7.2. Blood Donation Centres
7.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
7.2.3. Market Opportunity Analysis
7.3. Diagnostic Centers
7.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
7.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
7.3.3. Market Opportunity Analysis
8. Global Hepatitis C Virus Testing Market Forecast, By Region, 2014 - 2018 and Forecast, 2019 - 2025
8.1. North America
8.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.1.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.2.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.3.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.4.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 Revenue, USD Mn
8.5.2. Year-over-Year Y-o-Y Growth Analysis % and Market Share Analysis %
8.5.3. Market Opportunity Analysis
8.6. Global Hepatitis C Virus Testing Market- Opportunity Analysis Index - By Test Type, By Technique, By End User, and Region, 2019 – 2025
9. North America Hepatitis C Virus Testing Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
9.1.1. Test Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
9.1.1.1. Hepatitis C Antibody Test
9.1.1.2. Hepatitis C RNA Quantitative Test
9.1.1.3. Hepatitis C RNA Qualitative Test
9.1.1.4. Hepatitis C RIBA
9.1.1.5. Hepatitis C Genotype
9.1.1.6. Viral Load
9.1.2. Technique Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
9.1.2.1. Polymerase Chain Reaction Tests
9.1.2.2. Immunoassays
9.1.2.3. Others
9.1.3. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
9.1.3.1. Hospitals
9.1.3.2. Diagnostic Centres
9.1.3.3. Blood Donation Centres
9.1.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn Y-o-Y Growth % and Market Share %
9.1.4.1. U.S.
9.1.4.2. Canada
9.1.5. North America Hepatitis C Virus Testing Market- Opportunity Analysis Index - By Test Type, By Technique, By End User, and Country, 2019 – 2025
9.1.6. North America Hepatitis C Virus Testing Market Dynamics – Trends
10. Europe Hepatitis C Virus Testing Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
10.1.1. Test Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.1.1. Hepatitis C Antibody Test
10.1.1.2. Hepatitis C RNA Quantitative Test
10.1.1.3. Hepatitis C RNA Qualitative Test
10.1.1.4. Hepatitis C RIBA
10.1.1.5. Hepatitis C Genotype
10.1.1.6. Viral Load
10.1.2. Technique Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.2.1. Polymerase Chain Reaction Tests
10.1.2.2. Immunoassays
10.1.2.3. Others
10.1.3. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.3.1. Hospitals
10.1.3.2. Diagnostic Centres
10.1.3.3. Blood Donation Centres
10.1.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
10.1.4.1. Germany
10.1.4.2. UK
10.1.4.3. France
10.1.4.4. Spain
10.1.4.5. Italy
10.1.4.6. Russia
10.1.4.7. Poland
10.1.4.8. Rest of Europe
10.1.5. Europe Hepatitis C Virus Testing Market- Opportunity Analysis Index - By Test Type, By Technique, By End User, and Country, 2019 – 2025
10.1.6. Europe Hepatitis C Virus Testing Market Dynamics – Trends
11. Asia-Pacific Hepatitis C Virus Testing Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
11.1.1. Test Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.1.1. Hepatitis C Antibody Test
11.1.1.2. Hepatitis C RNA Quantitative Test
11.1.1.3. Hepatitis C RNA Qualitative Test
11.1.1.4. Hepatitis C RIBA
11.1.1.5. Hepatitis C Genotype
11.1.1.6. Viral Load
11.1.2. Technique Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.2.1. Polymerase Chain Reaction Tests
11.1.2.2. Immunoassays
11.1.2.3. Others
11.1.3. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
11.1.3.1. Hospitals
11.1.3.2. Diagnostic Centres
11.1.3.3. Blood Donation Centres
11.1.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn,
Y-o-Y Growth %, and Market Share %
11.1.4.1. Japan
11.1.4.2. China
11.1.4.3. India
11.1.4.4. ASEAN
11.1.4.5. Australia & New Zealand
11.1.4.6. Rest of Asia-Pacific
11.1.5. Asia-Pacific Hepatitis C Virus Testing Market- Opportunity Analysis Index - By Test Type, By Technique, By End User, and Country, 2019 – 2025
11.1.6. Asia-Pacific Hepatitis C Virus Testing Market Dynamics – Trends
12. Latin America Hepatitis C Virus Testing Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
12.1.1. Test Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.1.1. Hepatitis C Antibody Test
12.1.1.2. Hepatitis C RNA Quantitative Test
12.1.1.3. Hepatitis C RNA Qualitative Test
12.1.1.4. Hepatitis C RIBA
12.1.1.5. Hepatitis C Genotype
12.1.1.6. Viral Load
12.1.2. Technique Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.2.1. Polymerase Chain Reaction Tests
12.1.2.2. Immunoassays
12.1.2.3. Others
12.1.3. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.3.1. Hospitals
12.1.3.2. Diagnostic Centres
12.1.3.3. Blood Donation Centres
12.1.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
12.1.4.1. Brazil
12.1.4.2. Mexico
12.1.4.3. Argentina
12.1.4.4. Venezuela
12.1.4.5. Rest of Latin America
12.1.5. Latin America Hepatitis C Virus Testing Market- Opportunity Analysis Index - By Test Type, By Technique, By End User, and Country, 2019 – 2025
12.1.6. Latin America Hepatitis C Virus Testing Market Dynamics – Trends
13. Middle East & Africa Hepatitis C Virus Testing Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
13.1.1. Test Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.1.1. Hepatitis C Antibody Test
13.1.1.2. Hepatitis C RNA Quantitative Test
13.1.1.3. Hepatitis C RNA Qualitative Test
13.1.1.4. Hepatitis C RIBA
13.1.1.5. Hepatitis C Genotype
13.1.1.6. Viral Load
13.1.2. Technique Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.2.1. Polymerase Chain Reaction Tests
13.1.2.2. Immunoassays
13.1.2.3. Others
13.1.3. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth % and Market Share %
13.1.3.1. Hospitals
13.1.3.2. Diagnostic Centres
13.1.3.3. Blood Donation Centres
13.1.4. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn, Y-o-Y Growth %, and Market Share %
13.1.4.1. Gulf Cooperation Council GCC Countries
13.1.4.2. Israel
13.1.4.3. South Africa
13.1.4.4. Rest of MEA
13.1.5. MEA Hepatitis C Virus Testing Market- Opportunity Analysis Index - By Test Type, By Technique, By End User, and Country, 2019 – 2025
13.1.6. MEA Hepatitis C Virus Testing Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis
14.2.1. Abbott Laboratories U.S.
14.2.2. Bio Rad Laboratories Inc. U.S.
14.2.3. Qiagen Germany
14.2.4. Bayer AG Switzerland
14.2.5. OraSure Technologies U.S.
14.2.6. Siemens Healthcare GmbH Germany
14.2.7. BioGenex U.S.
14.2.8. H. Hoffman-La Roche Ltd Switzerland
14.2.9. Thermo Fisher Scientific Inc. U.S.
14.2.10. Ortho Clinical Diagnostic Inc. U.S.
15. Research Methodology
16. Key Assumptions and Acronyms


Please fill the following form to know more details about this Report




RELATED PRODUCTS



CHOOSE A FORMAT


  •  Single User Price : $ 4400
  •  Enterprise User License : $ 6600
  •  Corporate User License : $ 8900

Have A Question ?


  DOWNLOAD SAMPLE



TESTIMONIALS

I am completely satisfied with the information given in the sample pages of the report and I am waiting for the affirmative response from my peers and colleagues to purchase it.hey answered to all my queries promptly. I am highly satisfied!!
John Keats
We received a very quick response to all our queries on the RTLS report and we were also given a free consult with analyst for 15 minutes. It is refreshing (and increasingly rare) to have a new company go the extra mile to win the confidence of the customer
Ernest Hemingway
I would like to express my gratitude for the excellent service received this morning from the support team. They acknowledged my concern of adding me to the secondary user's list immediately. Thank you for this excellent, speedy and thoughtful service
Jacob Watson

CUSTOM RESEARCH

Still haven't found what you're looking for ?
Speak to our Custom Research Team